Squarepoint’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Sell
12,839
-146,587
-92% -$11.6M ﹤0.01% 2724
2025
Q4
$12.4M Sell
159,426
-191,820
-55% -$13M 0.03% 982
2025
Q3
$19.9M Buy
351,246
+317,922
+954% +$14.3M 0.04% 751
2025
Q2
$1.45M Sell
33,324
-15,865
-32% -$546K ﹤0.01% 2335
2025
Q1
$1.35M Buy
49,189
+815
+2% +$29.7K ﹤0.01% 2403
2024
Q4
$1.95M Sell
48,374
-25,151
-34% -$1.14M 0.01% 2447
2024
Q3
$3.48M Sell
73,525
-35,038
-32% -$1.55M 0.01% 1676
2024
Q2
$3.24M Buy
108,563
+23,312
+27% +$807K 0.01% 1685
2024
Q1
$3.43M Buy
85,251
+57,053
+202% +$2.04M 0.01% 1725
2023
Q4
$718K Sell
28,198
-2,190
-7% -$39.2K ﹤0.01% 2752
2023
Q3
$422K Buy
+30,388
New +$611K ﹤0.01% 2922
2023
Q1
Sell
-21,878
Closed -$546K 3541
2022
Q4
$546K Sell
21,878
-97,003
-82% -$2.59M ﹤0.01% 2226
2022
Q3
$2.59M Buy
118,881
+39,553
+50% +$1.04M 0.02% 1145
2022
Q2
$1.56M Buy
+79,328
New +$1.85M 0.01% 1341
2021
Q4
Sell
-14,499
Closed -$852K 3363
2021
Q3
$852K Sell
14,499
-34,316
-70% -$1.99M 0.01% 1655
2021
Q2
$2.37M Buy
48,815
+34,404
+239% +$1.49M 0.02% 1088
2021
Q1
$560K Buy
+14,411
New +$867K 0.01% 1936
2020
Q4
Sell
-9,045
Closed -$292K 3111
2020
Q3
$292K Buy
+9,045
New +$276K ﹤0.01% 1815

Other funds holding KYMR